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Abstract: Pre-exposure prophylaxis (PrEP) is a novel bio-medical HIV prevention op-
tion for individuals at high risk of HIV exposure. This qualitative interview study ex-
plores perceptions and understandings of PrEP among a sample of 20 HIV-negative 
and HIV-positive men who have sex with men (MSM) in the UK, where there is a 
debate about the feasibility of offering PrEP on the NHS. Data were analysed using 
qualitative thematic analysis and social representations theory from social psychol-
ogy. The following three themes are discussed: (1) uncertainty and fear, (2) man-
aging relationships with others, and (3) stigma and categorization. HIV-negative 
interviewees generally perceived PrEP as a risky solution for “high risk” individuals, 
while HIV-positive individuals regarded it as potentially enhancing interpersonal 
relations between serodiscordant partners. Social stigma overwhelmingly under-
pinned individuals’ perceptions of PrEP. This might inhibit access to PrEP among 
those who might benefit most from it, thereby undermining HIV prevention efforts.
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article explores perceptions and understandings 
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1. Introduction
Pre-exposure prophylaxis (PrEP) is a novel bio-medical HIV prevention option for individuals at high 
risk of HIV exposure. The drug Truvada®, consisting of the two reverse transcriptase inhibitors emtric-
itabine and tenofovir, is currently approved for use as PrEP in the US and in clinical trials in the UK. 
Clinical trials in a number of countries and contexts converge in evidencing the high effectiveness of 
PrEP as a means of preventing HIV infection (Anderson et al., 2012). In 2012, the Food and Drug 
Administration (FDA) approved PrEP for use in the US. PrEP is not currently available in the UK, al-
though there is a campaign for it to be made available on the UK National Health Service (NHS) to 
individuals at high risk of HIV acquisition. There has been some social sciences research into atti-
tudes towards PrEP (Brooks et al., 2012; Tangmunkongvorakul et al., 2013), much of which has fo-
cused on clinical trial participants or on HIV-negative individuals in the US who have access to PrEP. 
However, there has been no UK-based research into attitudes towards PrEP among HIV-negative 
and HIV-positive men who have sex with men (MSM). MSM constitute the group most affected by HIV 
in the UK (Public Health England, 2015). Using a qualitative interview design, this study explores 
perceptions and understandings of PrEP among a small sample of MSM in the UK, where PrEP is set 
to become a reality. The aim is to provide some preliminary insights into perceptions and under-
standings of PrEP in this population.
1.1. Approaches to HIV prevention
Human Immunodeficiency Virus (HIV) is the virus that causes Acquired Immune Deficiency Syndrome 
(AIDS). Globally, some 36 million people have died of AIDS since its first clinical observations in 1981, 
and it is estimated that 35.3 million people are currently living with HIV.1 According to Public Health 
England (2015), HIV prevalence in the UK population aged between 15–59 is 0.19%—Approximately, 
103,700 people are living with the virus, 17% of whom are unaware of their infection. MSM constitute 
the group at highest risk of HIV acquisition in the UK. It is estimated that some 45,000 MSM were 
living with HIV in 2014 and 1 in 11 MSM in London is HIV-positive. In 2014, a total of 5,850 individuals 
were diagnosed with (sexually transmitted) HIV, which represents a slight increase from 2013. Of 
these new diagnoses, 3,360 (57%) were MSM. HIV transmission among MSM shows no signs of hav-
ing decreased over the last decade.
In the absence of a vaccine or cure, prevention remains the most effective strategy against HIV. 
The promotion of condom use has long been the preferred policy strategy in most countries 
(Abraham, Krahé, Dominic, & Fritsche, 2002). Although condoms remain a highly effective preven-
tion tool, both for HIV and other STIs, rising HIV incidence suggests that not everybody uses them 
consistently. Condom fatigue among MSM despite the risk of HIV has been studied in several con-
texts (Rowniak, 2009; Shernoff, 2006). This work identifies other prevention techniques used by MSM. 
For instance, many engage in “serosorting”, that is, they may have condomless sex with individuals 
who they believe share their HIV status (Golden, Stekler, Hughes, & Wood, 2008). However, almost 
one fifth of HIV-infected individuals in the UK are unaware of their status and, due to the social 
stigma, some may choose not to disclose it. More recently, treatment as prevention has emerged as 
an effective strategy given that antiretroviral treatment (ART) suppresses the HIV-infected individu-
al’s viral load, often to “undetectable” levels,2 which significantly reduces their risk of transmitting 
HIV to sexual partners (Attia, Egger, Müller, Zwahlen, & Low, 2009). However, many new infections 
occur as a result of sexual intercourse with an undiagnosed and, thus, untreated HIV-infected indi-
vidual. Incidentally, those with acute HIV infection are perhaps less likely to be aware of their infec-
tion but will present a high viral load. Rising HIV incidence has led to debates around biomedical 
prevention strategies, the most prominent of which is PrEP.
1.2. The emergence of PrEP: Opportunities and risks
A series of clinical trials, including iPrEx (Grant et al., 2010), Partners PrEP (Baeten et al., 2012) and 
PROUD (McCormack et al., 2016), have demonstrated the effectiveness of orally administered PrEP. 
Following the PROUD clinical trial, NHS England has been evaluating PrEP but it is unlikely that any 
decision will be made about its provision on the NHS until 2017.3 In arguments against PrEP, the fol-
lowing specific concerns have been cited:
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•  PrEP is often positioned as a prevention technique that should be used alongside condoms. 
However, critics have voiced concerns that PrEP may obviate the perceived need to use condoms 
and thereby increase the incidence of other STIs.
•  Adherence to PrEP is central to its effectiveness. Given that drug adherence is a concern among 
many HIV patients (Fogarty et al., 2001), critics fear similar problems with adherence to PrEP 
which could decrease its effectiveness. HIV infection could occur during a window of low drug 
exposure due to poor adherence. Incidentally, recent attitudinal research suggests that one’s 
HIV-negative serostatus may create complacency vis-à-vis adherence to PrEP 
(Tangmunkongvorakul et al., 2013).
•  Clinical trials have found no evidence that PrEP causes serious side effects, although minor side 
effects (e.g. nausea, stomach pains, loss of appetite) have been observed in some patients. 
Conversely, concerns have been raised about possible long-term side effects (e.g. decreased 
kidney function, reduction in bone density).
•  HIV-infected individuals must never use PrEP because this can lead to viral mutations and, thus, 
drug resistance. It is possible that an individual who takes an HIV test during the acute infection 
stage will test negative for the virus. Use of only two anti-HIV agents (emtrictabine and tenofovir 
disproxil fumarate) instead of three could give rise to drug resistance, thereby limiting future 
treatment options. There are concerns that newly infected individuals who are unaware of their 
positive serostatus may take PrEP and develop drug resistance.
These concerns have influenced media and policy debates concerning PrEP, thereby contributing 
to societal thinking about the prevention tool (Jaspal & Nerlich, 2016). As highlighted in this article, 
some of these concerns are also observable in MSM’s attitudes towards PrEP in the US.
1.3. MSM’s perspectives on PrEP
Although PrEP has been available in the US since 2012, uptake has been relatively low (Flash et al., 
2014). Research in a number of US cities suggests that low awareness of PrEP is a key impediment 
to uptake. In a recent survey of MSM in Boston, Pittsburgh and San Juan (Puerto Rico) (Dolezal et al., 
2015), it was found that only 21% of respondents had heard of PrEP. However, when PrEP was ex-
plained to respondents, the mean intention to use it was high (9.1 in San Juan and 7.7 in Boston, on 
a 10-point scale), suggesting that greater awareness and understanding may contribute to greater 
endorsement. It is noteworthy that there appears to be low levels of awareness of PrEP in demo-
graphic groups at highest risk of HIV infection. For instance, only 23.4% of the 436 Black MSM sur-
veyed in Atlanta, Georgia were aware of PrEP (Eaton, Driffin, Bauermeister, Smith, & 
Conway-Washington, 2015).
However, there is no straightforward correlation between awareness of and intention to use 
PrEP—MSM who are aware of PrEP do not automatically endorse it as a prevention tool. Barriers to 
using PrEP include inter alia HIV-related stigma (Wade Taylor et al., 2014), concern over side effects 
(Kubicek, Arauz-Cuadra, & Kipke, 2015) and concerns that it might not be reliably protective against 
HIV (Golub, Gamarel, Rendina, Surace, & Lelutiu-Weinberger, 2013). Among Australian MSM, willing-
ness to use PrEP declined between 2011 and 2013 from 28.8 to 23.3% respectively (Holt et al., 2014). 
In their US survey study, Gamarel and Golub (2015) found that higher risk perception, intimacy mo-
tivations for condomless sex and recent condomless sex independently predicted PrEP adoption in-
tentions. Risk perception plays an important role in determining use intentions—78% of the MSM 
who met the behavioural criteria for PrEP did not perceive their risk to be significant enough to war-
rant PrEP use (Gallagher et al., 2014). In their study of ethnic minority MSM in the UK, Jaspal et al. 
(2016) found that participants who perceived their sexual behaviour as low risk actually had the 
poorest knowledge of HIV. Saberi et al. (2012) found that the likelihood of using PrEP in the future 
was positively correlated with unprotected insertive anal intercourse and negatively associated with 
unprotected receptive anal intercourse (the highest-risk behaviour). This research suggests that in-
dividuals’ subjective risk estimates are not always consistent with objective risk, which can obviate 
the perceived need for PrEP among those who could benefit from it.
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Sexual risk-taking has also been associated with PrEP use although findings are inconsistent. 
While Brooks et al. (2012) found that 64% of their respondents acknowledged a likely increase in 
sexual-risk taking, including the complete abandonment of condom use, Barash and Golden (2010) 
found no association between sexual risk-taking behaviour and interest in taking PrEP. Given the 
social stigma appended to (unprotected) casual sex, which has been referred to as “slut shaming” 
(McDavitt & Mutchler, 2014), individuals may attempt to adhere to the coercive social norm of prac-
ticing safer sex. The present study explores how MSM in the UK foresee the potential impact of PrEP 
on their own sexual behaviour. Moreover, while existing research has understandably focused on 
HIV-negative MSM’s perceptions of PrEP given that PrEP is a prevention method, the present study 
also explores how HIV-positive MSM perceive the prevention tool and its possible impact for relations 
with HIV-negative MSM.
1.4. Social representations theory
Social representations theory (Moscovici, 1988) provides a useful framework for understanding the 
development of perceptions of PrEP. At a basic level, a social representation can be defined as a col-
lective “elaboration” of a given social object which enables individuals to think and talk about it. For 
the purposes of this study, this elaboration consists of emerging beliefs, values, ideas, images and 
metaphors in relation to PrEP. Two principal social psychological processes converge in the creation 
of social representations:
•  anchoring refers to the process whereby a novel, unfamiliar phenomenon is integrated into ex-
isting ways of thinking. For instance, Spieldenner (2016) has observed that PrEP use is linked to 
sexual promiscuity which has given rise to the terms “PrEP Whore” and “Truvada Whore” to 
characterize users.
•  objectification refers to the process whereby an abstract phenomenon is rendered concrete and 
tangible. Jaspal and Nerlich (2016) have noted the use of militaristic metaphors of PrEP as a 
“weapon” in the “battle” against HIV.
Breakwell (2014) has outlined the processes that underpin the individual’s relationship with a so-
cial representation. The individual takes a stance on a given social representation, that is, they differ 
in the extent to which they are aware of, understand, accept, and assimilate to their thinking a social 
representation. For instance, while an individual may be aware of PrEP, they may understand it in 
similar terms to the contraceptive pill due to the societal anchoring of PrEP to the contraceptive pill. 
This could have important implications for how MSM engage with and behave in relation to the pre-
ventive tool. The present study identifies and describes the overarching social representations dis-
cernible in UK MSM’s accounts of PrEP.
2. Method
2.1. Participants
Using a snowball sampling strategy, 20 MSM were recruited in the East Midlands and in West London, 
UK. It is habitual to conduct qualitative research with fairly small sample sizes because the primary 
aim is to gain a deep and detailed understanding of a given phenomenon rather than to generate 
generalizable data (Braun & Clarke, 2006; Smith & Osborn, 2008). Therefore, it was decided that a 
sample of 20 participants would be sufficient for the purpose of the present study. Ten individuals 
were White British, four were Black British, three were of South Asian heritage, and three were Latin 
American. Nine participants had been diagnosed with HIV, and 11 had tested HIV-negative at their 
last test. Participants were aged between 18 and 48 years (M = 31.6). Eight participants had univer-
sity-level qualifications, eight had completed college education, and four reported having no formal 
qualifications. Although all of the HIV-positive interviewees had heard of PrEP before participating in 
this study, only six of the HIV-negative interviewees had knowledge of it which they believed to be 
cursory.
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2.2. Procedure and analytic approach
These data are drawn from an interview study focusing on aspects of identity and sexual health 
among HIV-negative and HIV-positive MSM. In this study, interviewees were asked their views re-
garding PrEP. Interviews were guided by a semi-structured interview schedule consisting of a series 
of exploratory, open-ended questions. The schedule began with questions regarding self-description 
and identity, followed by some questions/probes that elicited information concerning sexual behav-
iour and sexual risk-taking, attitudes towards PrEP and users of PrEP, and interpersonal relations 
with other MSM. Interviews lasted between 60 and 90 min, and were digitally recorded and tran-
scribed verbatim.
The data were analysed using qualitative thematic analysis, which has been described as “a meth-
od for identifying, analysing and reporting patterns (themes) within data” (Braun & Clarke, 2006, p. 
78). Thematic analysis is a flexible qualitative technique that allows the analyst to identify key per-
ceptions of, and meanings attributed to, a particular phenomenon. This approach can shed light on 
the subjective perceptual processes associated with participants’ attempts to make sense of a phe-
nomenon like PrEP. Moreover, its idiographic mode of enquiry facilitates in-depth exploration of how 
each individual conceptualized PrEP, the meanings he attributed to it, and how PrEP might affect 
their lives and personal relationships.
The authors transcribed the recordings and studied the transcripts. During each reading of the 
transcripts preliminary interpretations were noted in the left margin. These included inter alia par-
ticipants’ meaning-making, particular forms of language, and apparent contradictions and patterns. 
Initial codes aimed to capture, from the analyst’s perspective, participants’ attempts to make sense 
of the object of analysis. Then the right margin was used to collate these initial codes into potential 
themes, which captured the essential qualities of the accounts. The list of themes was reviewed 
rigorously against the data to ensure their compatibility and numerous interview extracts were list-
ed against each corresponding theme. At this stage specific interview extracts, which were consid-
ered representative of the themes, were selected for presentation in this article. Finally, three 
superordinate themes which reflected the analysis were developed and ordered into a coherent 
narrative structure. In addition to the dominant themes in the interviews, the analysis identified key 
linguistic elements that performed the functions of anchoring and objectification. The superordinate 
themes can be considered social representations because they “assume a configuration where con-
cepts and images can coexist without any attempt at uniformity, where uncertainty as well as mis-
understandings are tolerated, so that discussion can go on and thoughts circulate” (Moscovici, 1988, 
p. 233).
3. Results
The analysis of HIV-negative and HIV-positive MSM’s reflections on PrEP can be summarized in terms 
of the following three themes: (1) uncertainty and fear, (2) managing relationships with others, and 
(3) stigma and categorization.
3.1. Uncertainty and fear
There is an established empirical link between uncertainty and fear (Grupe & Nitschke, 2013). A large 
body of research indicates that uncertainty surrounding future outcomes can fuel fear. The two 
constructs are considered in tandem because the data presented in the present study strongly sug-
gest that uncertainty about the effectiveness of PrEP generated fear of HIV infection despite adher-
ence to the preventative drug. Despite evidence from clinical trials that PrEP is highly effective in 
preventing HIV infection, HIV-negative individuals still manifested uncertainty and fear about its ef-
fectiveness. Several individuals described their anxiety after sexual encounters even when they had 
used condoms, highlighting the general fear of HIV infection among many MSM (Prestage et al., 
2012), and contrasted them with the prospect of using PrEP (an invisible prevention method). 
Accordingly, many anticipated greater anxiety about HIV infection after sex (with PrEP): 
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Well, they say it’s effective but it isn’t exactly a vaccine is it? Scientists can make mistakes 
too… With a condom you put it on and that’s it. You know what the score is. (Joel, 
HIV-negative)
I don’t trust the scientists. One minute it’s OK to just take it and then the next “oh sorry, we 
misjudged that” ... it’s like when they didn’t get the whole blood transfusions issue and loads 
of people wound up getting infected. (Keiron, HIV-negative)
As a relatively novel prevention tool, PrEP was perceived as an uncertain method of protecting 
oneself against HIV infection. This is contrast to previous research which has found that PrEP can 
reduce fear of HIV (Koester et al., 2014). Interestingly, there was a clear orientation towards a one-
shot HIV vaccine as the desired HIV prophylaxis. Indeed, in an analysis of the press coverage of PrEP 
(Jaspal & Nerlich, 2016), it has been found that some journalists in favour of the prophylactic tool 
often anchored it to vaccination and, in some cases, constructed it as surpassing a vaccine in terms 
of its benefits. Despite this misleading press tendency, some interviewees rejected this notion but, 
due to the cultural desirability of a vaccine, also appeared to reject the effectiveness of PrEP. 
Interviewees’ fear and uncertainty vis-à-vis PrEP additionally stemmed from their general mistrust 
of scientists and public health experts who “can make mistakes too.” Keiron described his fear that 
PrEP may fail by anchoring scientists’ knowledge on PrEP to their lack of knowledge concerning the 
contamination of blood products which led to HIV infections among recipients. This early error in the 
HIV/AIDS crisis re-surfaced in some interviewees’ minds and shaped scepticism towards PrEP.
Much of participants’ trepidation in relation to PrEP stemmed from uncertainty and, thus, fear sur-
rounding its potential (long-term) side effects (Grant et al., 2014). There was a clear tendency to 
anchor PrEP to earlier generations of ART which did cause side effects: 
It freaks me out, taking those pills and you don’t know the effects they will have … You know, 
people on medication wasting away. I do look after myself and my body and skin. All of that 
matters to me. (Ian, HIV-negative)
You know, you hear the stories about, you know, being forced to pump drugs into your body 
and people dying from it. What’s the need to pump drugs in your body unnecessarily? (Andy, 
HIV-negative)
Individuals focussed largely on the physical side effects of using as prophylaxis drugs currently 
used to treat HIV infection. Ian believed that PrEP might cause undesirable physical changes, there-
by undermining his efforts to “look after myself and my body and skin”. Upon closer scrutiny, it be-
came clear that he anchored PrEP to first-generation ART which could cause liphodystrophy and 
other physical changes. In short, Ian and others feared that they would become identifiable as PrEP 
users, due to the physical changes they believed to be associated with its use. This anchoring pro-
cess was similarly echoed in Andy’s reflections on PrEP as he associated it with “people dying from” 
the use of AZT in the early stages of the ART development.
In addition to the tendency to anchor PrEP to first-generation ART, there was consistent use of 
metaphors of force and aggression in the data. The objectification of taking PrEP as “being forced to 
pump drugs into your body” constructed a decreased sense of agency and self-efficacy in relation to 
sexual health. This metaphorical theme is in stark contrast to the perception among some users of 
PrEP that it conversely does provide greater choice and agency in protecting their sexual health 
(Grant & Koester, 2016). Although several interviewees acknowledged their own inconsistent use of 
condoms, on a conceptual level were evaluated as a more logical approach to HIV prevention than 
a biomedical approach involving “drugs”.
The impact of PrEP on one’s own sexual behaviour constituted an additional source of uncertainty 
for interviewees, as some believed that they might find it more difficult to use condoms 
consistently:
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In a way it sounds good I agree because I do sort of have [condom] slip ups quite a bit, like I 
have had unprotected sex a few times… But I think maybe it’s something to like improve on 
and with PrEP I reckon I’d stop altogether and that does worry me. (Kyle, HIV-negative)
Kyle referred to condomless sexual encounters as “slip ups” as he acknowledged the associated 
risks. Use of this term also suggested that condomless encounters were undesirable and that he 
wished to change this risky behaviour. This may be attributed to the social stigma appended to con-
domless sex in the MSM community (Shernoff, 2006), which is also sometimes reproduced by medi-
cal professionals (Grant & Koester, 2016). Upon reflection, Kyle feared that PrEP would accentuate 
his existing habit of not using condoms in casual sexual encounters, because it would provide pro-
tection against the STI he feared most, namely HIV. In short, Kyle expressed uncertainty about his 
future sexual behaviour which increased his fear of possible HIV infection. Like Kyle, several individu-
als quite honestly acknowledged the “competition” between PrEP and condoms and did not seri-
ously believe that they would use condoms consistently while taking PrEP (Brooks et al., 2012). This 
is in contrast to the advice given by both the FDA in the US and the research team leading the clinical 
trials in the UK.4
While the HIV-negative interviewees perceived fear and uncertainty in relation to PrEP, several 
HIV-positive individuals conversely regarded the prophylactic tool as a means of reducing fear and 
uncertainty brought on by their HIV diagnosis: 
When I was diagnosed, I felt terrible … I felt like a monster, that I was going to infect 
everyone. I was quite afraid… I think PrEP would give me more confidence and give my 
partners more security. (Miguel, HIV-positive)
HIV has been hanging over me, the virus, the condition. Negative folks just think I’m going 
round infecting left, right and centre but actually I’m undetectable. PrEP is just an added bit 
of security so it will calm us all down. (James, HIV-positive)
Since my diagnosis there’s still a niggling sort of worry I have about spreading the virus and 
it used to petrify me if I’m honest … This new thing might help to like soften me up a bit 
[laughs]. (Pete, HIV-positive)
The HIV-positive interviewees vividly described the negative social and psychological consequenc-
es of HIV stigma, which in many cases had produced decreased self-esteem and reduced connect-
edness between them and other (HIV-negative) MSM. Miguel, for instance, had clearly internalized 
HIV stigma. He continued to fear passing on the virus to others, a concern that can inhibit the forma-
tion of a positive sexual identity and inhibit sexual relations (van Kesteren, Hospers, Kok, & van 
Empelen, 2005). Similarly, James cited the misconception among some HIV-negative MSM that HIV-
positive individuals pose a health hazard due to their HIV status, which could decrease interest in 
sex. Interviewees believed that psychologically PrEP would provide them with increased confidence 
in negotiating sexual relations with partners, and that biologically it would also provide their sexual 
partners with further protection. In addition to treatment as prevention5 and condom use, PrEP con-
stituted “an added bit of security”. In short, PrEP could reduce uncertainty about onward HIV trans-
mission and, thus, decrease fear surrounding serodiscordant sexual relations.
As an HIV prevention tool, PrEP is only of direct biological benefit to HIV-negative individuals but 
these data show that it may also bring about social psychological benefits. In addition to increased 
certainty and reduced fear, HIV-positive interviewees felt that PrEP might obviate the need to en-
gage in difficult conversations about HIV:
It can make life a bit easier… There is a lot of second guessing. “Shall I ask him if he wants 
to?” then “will he use a condom or not?” (James, HIV-positive)
With PrEP, it might sort of like become a non-issue, right? (Jake, HIV-positive)
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HIV disclosure can be difficult due to fear of rejection (Courtenay-Quirk, Wolitski, Parsons, Gómez, 
& The Seropositive Urban Men’s Study Team, 2006). Interviewees described their own negative ex-
periences of disclosure in sexual contexts. This led some individuals to construe their HIV status as 
a private, individual matter, which they could therefore choose not to disclose. Some reportedly used 
more subtle ways of avoiding onward HIV transmission by suggesting condom use to their sexual 
partners, although they sometimes found it difficult to negotiate condom use. It could be difficult to 
convince their partners to use condoms without disclosing their own HIV status, thereby increasing 
the risk of rejection. However, Jake and James believed that PrEP would obviate the need for condom 
negotiation or HIV disclosure in order to avoid possible transmission. This echoed the broader per-
ception among HIV-positive interviewees that PrEP added a further layer of safety, thereby decreas-
ing possible feelings of insecurity and guilt.
3.2. Managing relationships with others
There was concern among interviewees about the impact that PrEP use might have on their per-
sonal relationships. Interestingly, despite the non-availability of PrEP in the UK, interviewees were 
acutely aware of the social stigma surrounding it, embodied by references to the “Truvada Whore” 
in the US context (Spieldenner, 2016). Individuals’ awareness of this stigma informed their own 
evaluation of PrEP: 
There is a bit of shame, you know, when you don’t use condoms and like what you supposed 
to do? Tell a guy “oh, we don’t need to worry about using condoms because I’m taking a 
tablet that lets me fuck raw?” It is a bit slutty sounding. (Ian, HIV-negative)
I often wonder how people would judge me for taking PrEP. In my culture (South Asian) 
let’s say we have a conservative culture… My parents don’t even know I’m gay. (Raj, 
HIV-negative)
Like Ian and Raj, several HIV-negative individuals felt uneasy about the potential social conse-
quences of disclosing PrEP use to others. This could be attributed to the coercive social norm of using 
condoms and the consequential social stigma appended to non-use of condoms among MSM. While 
non-use of condoms may be socially represented as irresponsible and reckless, condomless sex is 
nevertheless practiced though not discussed openly (Shernoff, 2006). There was a pervasive percep-
tion among interviewees that PrEP and condoms were mutually exclusive and would therefore not 
be used in conjunction. Individuals avoided enthusiasm about non-use of condoms as some felt that 
this would portray them as “slutty” and “irresponsible” and there was, thus, a discernible sense of 
shame surrounding PrEP use in lieu of condoms (McDavitt & Mutchler, 2014).
Similarly, Raj feared judgement from others, although his account exhibited an additional layer of 
complexity. While most respondents considered PrEP through the lens of their gay identity, which 
was generally recognized as placing them at increased risk of HIV exposure, some also considered 
PrEP from the perspective of other identities, such as their ethno-cultural group membership. Raj 
described his ethno-cultural ingroup as “conservative” which had discouraged him from disclosing 
his sexual identity to his parents and other ingroup members. Raj’s socialization in his ethno-cultural 
group appeared to have led to increased shame surrounding aspects of his sexual identity, including 
how to safeguard his sexual health as a MSM. Consequently, he worried about the added stigma that 
he might face as a PrEP user, and he anticipated difficulties in concealing his PrEP use from family 
members.
There were also some positive observations about PrEP among HIV-negative interviewees: 
PrEP seems to give you a lot of choice though, I’ve got to say … I mean that sometimes you 
can’t really have that conversation about what you want to do and don’t want, like in a 
condom kind of sense, but with PrEP you’d take it in the morning right? That’s good. (Andy, 
HIV-negative)
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MSM can find it difficult to discuss HIV and to negotiate condom use particularly before/ during a 
sexual encounter (Shernoff, 2006). Andy, who had previously used the metaphor of “pumping drugs 
into your body” in his reflections on PrEP, did acknowledge the self-efficacy that PrEP might provide 
in relation to sexual health. He felt that this would enable individuals to take control of their sexual 
health without external pressures from others. Some interviewees did acknowledge that PrEP was 
safer than relying on one’s sexual partner to report their HIV status accurately, but few HIV-negative 
individuals reported willingness to use it themselves. This could be attributed to the social stigma 
surrounding it.
HIV-positive respondents felt optimistic about the positive impact that PrEP might have for their 
relationships with HIV-negative men, largely by removing the need to discuss HIV status at all: 
At the moment, it is difficult for me to imagine myself with a negative partner … I think 
PrEP could take away the barrier that exists between positive and negative guys. (Pedro, 
HIV-positive)
HIV status has come to constitute a group membership for many individuals, which has given rise 
to group divisions and problematic intergroup relations between HIV-negative and HIV-positive in-
dividuals (see also Grant & Koester, 2016). Among many HIV-negative individuals, this has led to the 
formation of negative and demeaning stereotypes about HIV-positive individuals, and many HIV-
positive individuals consequently anticipate rejection from serodiscordant partners. Pedro could not 
imagine a romantic relationship with an HIV-negative partner because he had experienced the ten-
sions that a positive serostatus can create in a serodiscordant relationship, such as fear of transmis-
sion. However, he perceived PrEP as a potential means of dismantling group divisions and problematic 
intergroup relations (“the barrier”) between HIV-negative and HIV-positive people, largely because 
it can reduce the risk of HIV transmission and, thus, reduce anxieties surrounding sexual intimacy. 
Similarly, Sam’s account suggested that PrEP could be liberating for him, as an HIV-positive MSM: 
I heard about it when I was in the US and I hooked up with a guy who had put it on his 
profile6 “on PrEP” and I was like “what’s that?” and he explained it, like it’s my way of 
protecting myself from HIV and I was like “awesome” because to be honest I’ve never liked 
condoms. (Sam, HIV-positive)
Fear of HIV transmission can constitute a serious impediment to positive interpersonal relations 
between HIV-negative and HIV-positive individuals. HIV-positive individuals may experience fear of 
infecting their partners which can lead to sexual abstinence, anxiety and other negative social psy-
chological outcomes. Some individuals choose not to use condoms for a variety of reasons (Shernoff, 
2006). Sam perceived PrEP as a means of enjoying condomless sexual intercourse without the as-
sociated anxiety of onward transmission. For Sam and other HIV-positive individuals, PrEP had the 
potential to shift the perceived responsibility of HIV prevention from the HIV-positive individual to 
the HIV-negative PrEP user. Moreover, at a psychological level, PrEP could potentially alleviate nega-
tive emotions such as anxiety, fear and indeed guilt when HIV-positive individuals prefer not to use 
a condom in a sexual encounter with an individual of a negative or unknown HIV status.
3.3. Stigma and categorization
Participants were acutely aware of the social stigma surrounding PrEP due to its anchoring to con-
domless sex and sexual risk-taking, which led some of the HIV-negative interviewees to distance 
themselves from it: 
It [PrEP] wouldn’t benefit me. I don’t take many risks, not much more than most guys on the 
scene. I suppose it’s for someone high-risk. (Alan, HIV-negative)
Jack (HIV-negative): I’m not like taking that many risks really so I’ve never thought this is for me.
Interviewer: What do you see as a risk?
Jack: Someone who is out at chemsex parties every weekend.
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Interviewees correctly noted that PrEP was intended for individuals at high risk of HIV infection, 
but there was a clear social stigma appended to the category “high risk”. Accordingly, HIV-negative 
individuals sought to distance themselves from this category in their reflections on PrEP. Alan re-
sisted the category “high risk” by attenuating the magnitude of the sexual risks that he took. He 
engaged in a form of downward comparison7 with “most guys on the [gay] scene” in order to present 
his own risk-taking as relatively trivial in contrast to others’ risk-taking. Indeed, Jack anchored the 
high risk category to participation in “chemsex” (drug use in sexualized settings) which itself carries 
the double stigma of casual sex with multiple partners and drug use (Bourne, Reid, Hickson, Torres 
Rueda, & Weatherburn, 2014). He was able to avoid self-positioning in this stigmatized category by 
constructing participation in chemsex as a central criterion for PrEP use. Although Jack did not en-
gage in chemsex, he did report condomless sexual encounters with multiple casual partners, which 
in fact did highlight his risk of HIV exposure. In resisting the stigmatized category “high risk”, Alan 
and others hastily concluded that PreP would not be of benefit to them. Furthermore, PrEP was an-
chored to sexual promiscuity, which further accentuated its stigma: 
I read an article that said “Truvada Whore”… It must be because this pill lets you have sex 
without condoms with loads of guys. I don’t really want to be that guy, to be fair. (Ian, 
HIV-negative)
Ian invoked the category “Truvada Whore” (an objectification of PrEP users) in order to illustrate the 
stigma of PrEP. More specifically, it was perceived as facilitating condomless sex with multiple partners. 
Given that HIV stigma can challenge self-esteem and cause depression (Lee, Kochman, & Sikkema, 
2002), it is natural that individuals would wish to distance themselves from it. The desire to resist the 
stigmatized category of “Truvada Whore” led some interviewees to reject the prospect of PrEP. Social 
stigma was similarly discernible in HIV-positive interviewees’ reflections on PrEP, which further con-
tributed to the cultural representation of PrEP as conducive to blithe risk-taking: 
In my generation and in my culture it was different. You didn’t talk about safer sex, or 
protection or anything, but now young guys are just being really risky. I reckon PrEP will 
increase this. (Pete, HIV-positive)
And it’s (PrEP), it’s. I’m not saying that’s a cause [of sexual risk-taking]. But it’s a contributor 
to, you know, people having more and more relaxed attitudes towards it. (Joe, HIV-positive)
The Prepsters8 don’t seem to give a shit about protecting themselves. They just think “HIV? 
Piece of cake” which it is not. (Samuel, HIV-positive)
Intergroup dynamics played an important role in participants’ thinking vis-à-vis PrEP. HIV-positive 
respondents differentiated themselves from HIV-negative MSM whom they viewed as excessively 
complacent about the risks associated with condomless sex. Given their positive serostatus, they 
regarded the consistency of their own condom use as a non-issue but appeared to stigmatize MSM 
who did not consistently use condoms, thereby contributing to the stigma of unprotected casual 
sex. Joe euphemistically referred to “relaxed attitudes” towards safer sex, while Sam more forcefully 
described the complacency of HIV-negative men who reportedly hold misguided, erroneous views 
concerning HIV. There was a further layer of social group dynamics observable in the accounts of 
older HIV-positive MSM who had been diagnosed during the early stages of the epidemic. Older par-
ticipants living with HIV lamented the complacency of younger gay men whom they viewed as 
blithely engaging in sexual risk-taking behaviours. PrEP use was thus anchored to irresponsibility. 
Pete, who was diagnosed in the 1980s, differentiated the “culture” of his generation from that of 
younger generations. He attributed his infection to the lack of public knowledge concerning HIV at 
that time and, conversely, criticized sexual risk-taking among younger gay men who were socialized 
in a culture cognizant of the risk of HIV infection. Like Joe who was diagnosed recently, some HIV-
positive interviewees viewed PrEP as a “contributor” to the general complacency regarding HIV 
among gay men: 
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For a lot of people it’s [PrEP] used as an excuse for people to have sex without a condom. 
(James, HIV-positive)
PrEP for me basically means “I’m neg and I like it raw”. (Mike, HIV-positive)
Although most HIV-positive interviewees highlighted the potential benefits of PrEP for decreasing 
HIV stigma, they themselves contributed to the social stigma concerning PrEP. James perceived it as 
an “excuse” to engage in risky sexual behaviors, thereby challenging the notion that PrEP provides 
an added layer of protection (in addition to condoms) against HIV infection. Similarly, Mike inter-
preted PrEP use as a means of implicitly expressing their desire to engage in condomless sex. PrEP 
was viewed as potentially facilitating “irresponsible” sexual behavior. Those HIV-positive interview-
ees who endorsed it in principle also warned of the potential public health risks associated with it: 
But I think as long as it is used correctly. It probably shouldn’t be something that anyone can 
just decide they can go on PrEP and because that may potential encourage them [to have 
condomless sex]. (Ken, HIV-positive)
I say to people that it’s a temporary measure and it’s just going to allow people to have 
riskier activities. (Pete, HIV-positive)
While cognizant of some of the benefits of PrEP, Ken and Pete reiterated the concerns raised by 
other HIV-positive interviewees surrounding the increase in sexual risk-taking. Ken implied that it 
would not be “used correctly”, i.e. in conjunction with condoms. Thus, he advocated greater regula-
tion of PrEP. He and others found it a risky public health strategy to make PrEP available to those 
individuals whose condom use is already inconsistent. Incidentally, there is a strong argument for 
offering PrEP to people at high risk of HIV infection because their condom use is inconsistent. 
Similarly, Pete did not regard PrEP as a particularly useful long-term public health strategy for reduc-
ing HIV incidence, referring to it as a “temporary measure” that might increase risk-taking. Some 
HIV-positive interviewees emphasized the status of PrEP as a temporary public health measure.
4. Discussion
While most previous studies have explored PrEP acceptability among individuals involved in clinical 
trials, i.e. those already taking PrEP, the present study set out to understand perceptions of PrEP 
among HIV-negative MSM who had never used it and among HIV-positive MSM who would not per-
sonally benefit from PrEP as a chemoprophylaxis but who may nevertheless be affected socially and 
psychologically by its availability. Interviewees strove to construct a social representation of PrEP 
that could enable them to think and communicate about it. Among HIV-negative MSM, these repre-
sentations were characterized by social stigma that focused largely around HIV stigma, sexual risk-
taking, and shame surrounding unprotected sex. HIV-positive interviewees also reproduced social 
stigma in relation to PrEP but unanimously acknowledged the potential social psychological benefits 
of implementing the preventive tool, particularly for improving interpersonal relations between peo-
ple of serodiscordant status (Grant & Koester, 2016). Therefore, it is possible to refer to two distinct 
social representations: (1) among HIV-negative individuals, there was a representation of PrEP as a 
risky solution for “high risk” individuals, and (2) among HIV-positive individuals, there was a repre-
sentation of PrEP as potentially enhancing interpersonal relations. These representations guided 
interviewees’ engagement with PrEP.
Despite the high effectiveness of PrEP as an HIV prevention tool, as demonstrated in numerous 
clinical trials, there appears to be considerable scepticism towards PrEP among HIV-negative MSM 
who could potentially benefit from it. There was generally low awareness of the mechanisms of PrEP, 
which led individuals to attempt to make sense of the biomedical prevention method by anchoring 
it to other things that they already knew about (Moscovici, 1988). For instance, some interviewees 
compared PrEP to a vaccine and, thus, rejected it as an inferior HIV prevention tool, partly because 
an HIV vaccine has been represented as the prime goal of HIV science. Others anchored PrEP to older 
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generations of ART, such as zidovudine, which caused visible physical changes, such as lipodystro-
phy in HIV patients (Bogner et al., 2001). This led them to express concerns about the possible long-
term side effects of using PrEP. Moreover, some interviewees manifested scepticism about its 
effectiveness because of a lack of trust in science, which was anchored to the early stages of the HIV 
epidemic during which many people were infected with HIV through blood transfusions and blood 
plasma products. Thus, uncertainty about possible side effects and the effectiveness of PrEP induced 
fear among interviewees. This could constitute a barrier to PrEP, as belief in the effectiveness of PrEP 
is key to its uptake (Chemnasiri et al., 2015).
Previous research and commentary on PrEP indicates that there is stigma surrounding the preven-
tion tool because it is regarded as facilitating condomless anal sex (Jaspal & Nerlich, 2016). Although 
PrEP has been represented as particularly suitable for MSM at high risk of HIV acquisition, such as 
those who do not use condoms consistently or those who have had a rectal STI in the last six months, 
the interview data clearly demonstrated that most HIV-negative interviewees resisted self-inclusion 
in the category “high risk.” This could be attributed to the social stigma appended to this category. 
In view of the stigma, they were motivated socially and psychologically to present themselves as 
“low risk” in order to protect their self-image. This can be attributed to the general perception that 
those at “high risk” are careless, lazy, irresponsible and foolish. Moreover, some interviewees an-
chored the notion of “high risk” to socially stigmatized sexual behaviors, such as engagement in 
drug use in sexualized settings (“chemsex”) and, thus, viewed themselves as ineligible for PrEP. 
Several theories of identity construction and self-presentation, such as Identity Process Theory 
(Jaspal & Breakwell, 2016), emphasize the importance of maintaining a sense of self-esteem, that is, 
a positive self-conception. It is easy to see how self-inclusion in the category “high risk” could poten-
tially challenge one’s self-esteem as well as one’s perceived worth in the eyes of others, which might 
prompt them to distance themselves from this category. This is consisistent with Joffe’s (2007) no-
tion of “othering” risk, which indicates the human tendency to attribute risk to others and to view 
oneself as being at low risk. Incidentally, several of the HIV-positive interviewees also appeared to 
contribute to the social stigma surrounding PrEP by linking its use to increased sexual risk-taking and 
by constructing PrEP users as complacent about safer sex practices.
Despite the social stigma that surrounded PrEP, which could plausibly discourage individuals from 
considering it a viable preventive option for themselves, both HIV-negative and HIV-positive MSM 
acknowledged the potential impact of PrEP on their interpersonal relations with others. HIV-negative 
men generally viewed PrEP as inducing tensions in interpersonal relations because they feared neg-
ative reactions from other people. For instance, some interviewees had not disclosed their sexual 
identity to others and felt that PrEP would add a further layer of complexity to their (hidden) sexual 
identities, while others feared that others might mistake PrEP for ART which reflected the stigma 
around HIV (Starks, Rendina, Breslow, Parsons, & Golub, 2013). Furthermore, in view of the stigma 
surrounding casual (condomless) sex, individuals felt that they would be reluctant to disclose their 
PrEP use to other people for fear of being labelled as sexually promiscuous or as sexual risk-takers. 
Thus, social stigma and the desire for positive self-presentation clearly underpinned the ways in 
which interviewees engaged with PrEP.
Although stigma and self-presentation also play a role in the development of attitudes towards 
PrEP among HIV-positive MSM, they appeared to hold more favorable social representations of the 
prevention tool. More specifically, PrEP was perceived as potentially reducing the risk of onward 
transmission which alleviated the feelings of uncertainty and anxiety that many HIV-positive MSM 
may experience in relation to sex with HIV-negative men (Bourne, Hickson, Keogh, Reid, & 
Weatherburn, 2012). Several individuals anticipated decreased guilt in relation to non-disclosure of 
HIV status and to engagement in condomless sex with other individuals of unknown HIV status. 
Incidentally, this was said to occur in contexts in which they did not feel comfortable disclosing their 
status or in contexts in which their partners did not wish to use condoms. More generally, while HIV-
negative MSM anticipated potential problems in managing interpersonal relations with others due to 
PrEP, HIV-positive individuals conversely regarded the preventive tool as a means of enhancing 
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interpersonal relations with others, particularly with HIV-negative partners. Some HIV-positive inter-
viewees described their negative experiences of disclosing their HIV status to sexual partners, such 
as rejection and even derision (see also Courtenay-Quirk et al., 2006). Furthermore, there were ac-
counts of how their HIV diagnosis had created interpersonal barriers between themselves and their 
existing HIV-negative partners, which sometimes culminated in relationship breakdown. This could 
severely challenge self-esteem and overall wellbeing among HIV patients (see Palmer & Bor, 2001). 
Conversely, there was a perception that PrEP might alleviate their own fears of transmitting the virus 
as well as their HIV-negative partners’ fears of contracting it during sex.
4.1. Implications
Given the small-scale nature of this interview study, the results are not easily generalizable to the 
MSM population. However, the data do shed light on some of the potential social and psychological 
challenges associated with the implementation and indeed uptake of PrEP among MSM, a popula-
tion that is disproportionately affected by HIV (Fish, Papaloukas, Jaspal, & Williamson, 2016). The 
results illuminate issues that will need to be addressed if PrEP is made available on the UK NHS. 
Social representations observable in press reporting on PrEP (Jaspal & Nerlich, 2016) appear to be 
reproduced by HIV-negative MSM although there was a general leaning towards more negative rep-
resentations, particularly when PrEP was discussed as a personal HIV prevention option. While indi-
viduals perceived it as a potentially viable HIV prevention tool at a population level, many rejected 
its suitability for themselves at a personal level. This is not at all to suggest that most MSM in the UK 
are opposed to personal use of PrEP and that they would refrain from using it if it were available. 
However, these data do elucidate some of the concerns manifested by MSM that could potentially 
discourage them from initiating and sustaining use of PrEP during episodes of sexual risk (Gallagher 
et al., 2014).
The prevalence of social stigma in relation to HIV, casual condomless sex (“slut shaming”), and 
PrEP could plausibly inhibit access to the prevention method among those at highest risk of HIV in-
fection. If PrEP does become available on the NHS, physicians may recommend it to their patients 
who appear to be at high risk of HIV acquisition. However, patients themselves may resist PrEP if 
they do not (wish to) view themselves as “high risk”. It is, thus, necessary to provide consistent and 
accurate information about HIV risk factors so that HIV-negative MSM can appraise their HIV risk 
more accurately and take adequate action to reduce their risk. Indeed, it has been demonstrated in 
recent research that those who perceive themselves to be at low risk are less likely to be knowledge-
able about HIV (Jaspal et al., 2016). Moreover, adherence to PrEP, which is key to its effectiveness, 
could be undermined by the social stigma that clearly surrounds it. People may wish to exit the 
stigmatized category “PrEP user” or miss doses of PrEP to avoid disclosure of their PrEP use. In short, 
HIV-negative MSM may feel uneasy about initiating and sustaining their use of PrEP due to social 
stigma.
The introduction of PrEP could also benefit HIV-positive patients, many of whom experience stig-
ma, prejudice and rejection particularly in their interactions with HIV-negative individuals. These 
negative experiences may lead to poor social, psychological and behavioral outcomes, such as poor 
adherence to HIV medication, low self-esteem, depression, self-isolation, alcohol/susbstance use, 
suicide ideation, and sexual risk-taking (Courtenay-Quirk et al., 2006). PrEP may generate greater 
awareness, understanding and discussion of HIV among MSM, thereby enhancing interpersonal rela-
tions between HIV-negative and HIV-positive individuals. The positive implications for HIV-positive 
MSM’s wellbeing may be considerable.
It is clear that PrEP is protective against HIV, but there are social, behavioral and psychological 
barriers to its success at a population level. In order to reap the full benefits of PrEP, the prevention 
tool needs to be communicated more effectively so that MSM are made aware of it and can under-
stand its mechanisms and the contexts in which it is likely to be most useful. Indeed, in previous 
quantitative research it has been shown that prior knowledge of PrEP is associated with a 1.5 higher 
uptake (Cohen et al., 2015). Moreover, greater awareness and understanding would help alleviate 
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some of the concerns manifested by HIV-negative MSM concerning the effectiveness of PrEP and its 
potential long-term side effects, which were cited as possible barriers to its uptake (see also Grant et 
al., 2014). When PrEP is presented as being “86% effectiveness against HIV”, 9for instance, it may 
understandably be resisted by individuals who wonder about the consequential 14% risk of infection 
– the possible reasons for this level of effectiveness (e.g. poor adherence in some of the clinical trial 
participants) ought to be explained to reduce concerns. Furthermore, there is clearly a need to chal-
lenge the social stigma associated with PrEP so that it can be perceived as a viable personal preven-
tion option among those individuals who may genuinely benefit from it. Campaigns that seek to 
normalize PrEP as one possible component of the existing HIV prevention toolbox may radically chal-
lenge negative perceptions and stereotypes that could inhibit access to PrEP. Rather than marketing 
PrEP as a drug for “guys that like to party”,10 for instance, it would be more effective to present it as 
a “further level of protection” against HIV, in addition to condoms and other prevention strategies. 
The societal perception that PrEP and condoms are mutually exclusive engenders further stigma and 
division at a time where acceptance and unity are key.
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Notes
1. http://www.unaids.org/en/resources/campaigns/global-
report2013/factsheet.
2. According to BHIVA guidelines (Fidler et al., 2013), an 
undetectable HIV viral load is defined as <50 copies/mL.
3. http://www.tht.org.uk/sexual-health/About-HIV/Pre-
exposure-Prophylaxis;  
http://www.prepaccess.org.uk/.
4. US Centre for Disease Control website  
http://www.cdc.gov/hiv/basics/prep.html.
5. Treatment as prevention (also referred to as “TasP”) 
is a public health strategy for reducing HIV incidence 
whereby HIV-positive individuals are allowed to com-
mence ART regardless of their CD4 count provided that 
they are ready to commit to treatment. ART reduces 
the individual’s viral load to an “undetectable” level. A 
suppressed viral load allows the CD4 count to rise, on 
the one hand, and renders the individual less infectious 
to others, on the other.
6. The participant was referring to an online profile on a 
geospatial gay social networking mobile application.
7. This refers to the process of comparing oneself to others 
on dimensions that will lead to a more favorable self-
evaluation and, thus, to enhanced self-esteem (Wills, 
1981).
8. Prepsters are a UK-based pressure group that “aims to 
educate and agitate for PrEP access in England and be-
yond.” http://prepster.info/about/.
9. This is the level of effectiveness reported by the PROUD 
clinical trial in the UK (McCormack et al., 2016).
10. Gilead Sciences funded a commercial for PrEP focusing 
on the slogan “I like to party”.  
http://www.advocate.com/hiv-aids/2015/11/05/watch-
new-prep-campaign-targets-men-who-party.
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